Due to the critical role of BCL9 in promoting tumor development in the Wnt/β-catenin signaling pathway, the specific regulation of BCL9 expression by HIF1α is considered to be an underlying crosstalk between Wnt/β-catenin signaling and hypoxia signaling pathways. The gene discussed is HIF1A; the disease is neoplasm.